RadarScreener › CLDI

CLDI

Calidi Biotherapeutics, Inc.
NYSE · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1855485) · 5 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

Reverse splits are how companies cure bid-price deficiencies; under 2026 rules they get one per 12 months.

Radar 58 (elevated attention) · dilution pressure elevated · listing risk elevated · governance risk elevated · runway 3.0 mo · strongest signal: Runway < 6 months (Jun 30, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

58Radar · attention score (0–100)
43Dilution pressure · financing + balance sheet
53Listing risk · exchange standards
51Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on CLDI
Alerts
One email the morning CLDI files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for CLDI back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$4.3Mcash + short-term investments as of Jun 30, 2026
3.0 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$3.1Mstockholders' equity as of Jun 30, 2026
$8.0Mpublic float (10-K cover)
2.6Mshares outstanding as of Aug 10, 2026 · was 19.3M May 8, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 13, 2026 Going-concern language “going concern periodic” language in 10-Q (10-Q) filed 2026-08-13 filing 33
Aug 13, 2026 Reverse split “reverse split” language in 8-K (EX-99.1) filed 2026-08-13 filing 32
Jul 31, 2026 Reverse split “reverse split” language in 8-K (8-K) filed 2026-07-31 filing 37
Jul 31, 2026 Holder rights modified 8-K Item 3.03 filed 2026-07-31 (accepted 17:00 ET) filing 33
Jun 30, 2026 Runway < 6 months ~3.0 months runway: liquidity $4,290,000 as of 2026-06-30, burn $17,173,250/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing 43
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans